Phosphate backbone of nucleic acids

The phosphate backbone of nucleic acids is the structural framework of DNA and RNA, composed of alternating sugar (deoxyribose or ribose) and phosphate groups linked by phosphodiester bonds (Berg et al., 2002). This backbone carries a consistent negative charge at physiological pH, which is vital for the stability of the double helix and serves as a primary docking site for various proteins, including histones and polymerases (Lodish et al., 2000). In a therapeutic context, the phosphate backbone is a critical site for drug interaction; many small molecules, such as aminoglycosides and intercalating agents, bind to it via electrostatic forces to disrupt microbial or cellular function (Vicens & Westhof, 2002). Furthermore, the backbone itself is often chemically modified in synthetic oligonucleotides, such as the use of phosphorothioate linkages in drugs like Nusinersen, to enhance metabolic stability and cellular uptake for treating genetic and viral diseases (Eckstein, 2000). Targeting or modifying the backbone is a fundamental strategy in antisense therapy, gene editing, and the development of traditional chemotherapeutic agents. Understanding the chemical properties of the phosphate backbone is essential for developing therapies that modulate gene expression or disrupt the replication of pathogens.

Other names

Phosphodiester backboneSugar-phosphate backboneDNA backboneRNA backboneNucleic acid backbone

Drugs interact with the phosphate backbone through electrostatic binding to the negatively charged oxygen atoms (e.g., aminoglycosides), covalent modification such as alkylation (e.g., certain nitrogen mustards), or by the therapeutic substitution of the phosphodiester linkage in synthetic oligonucleotides to enhance metabolic stability (Eckstein, 2000; Vicens & Westhof, 2002).